# SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries

> **NCT00114972** · PHASE3 · UNKNOWN · sponsor: **Boston Scientific Corporation** · enrollment: 1800 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Polymer-based Paclitaxel-Eluting TAXUS Express2-SR Stent
- **PROCEDURE:** Coronary Artery Bypass Surgery

## Key facts

- **NCT ID:** NCT00114972
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-03
- **Primary completion:** 2008-04
- **Final completion:** 2012-05
- **Target enrollment:** 1800 (ACTUAL)
- **Last updated:** 2010-06-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00114972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00114972, "SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00114972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*